氟哌啶醇联合或不联合吗啡对急性肾绞痛的镇痛效果比较:随机双盲临床试验
该随机双盲临床试验纳入140例疼痛评分大于3分的急性肾绞痛患者,随机分为两组:A组静脉给予吗啡联合氟哌啶醇,B组静脉给予吗啡联合生理盐水。在注射后0、20、40、60分钟采用0至10分视觉疼痛模拟量表记录疼痛严重程度。结果显示两组疼痛评分无显著差异(P=0.38),平均心率、收缩压、舒张压及恶心呕吐发生率均无显著差异;氟哌啶醇组锥体外系副作用发生率为4.3%,与对照组无显著差异;额外镇痛需求频率两组无显著差异(P=0.05)。作者结论认为氟哌啶醇未能减轻疼痛及恶心呕吐,反而引起锥体外系副作用,因此不推荐用于急性疼痛尤其肾绞痛。
要点
- 急性肾绞痛疼痛评分大于3分的患者中,吗啡联合氟哌啶醇与吗啡联合生理盐水相比,疼痛评分无显著差异(P=0.38)。
- 两组平均心率、平均收缩压、平均舒张压及恶心呕吐发生率均无显著差异。
- 氟哌啶醇组锥体外系副作用发生率为4.3%,与对照组无显著差异。
- 两组额外镇痛需求频率无显著差异(P=0.05)。
- 作者结论认为氟哌啶醇未能减轻疼痛及恶心呕吐,反而引起锥体外系副作用,不推荐用于急性疼痛尤其肾绞痛。
适用人群与场景
- 疼痛严重程度评分大于3分的急性肾绞痛患者。
诊断标准与关键阈值
- 采用0至10分视觉疼痛模拟量表(VPAS)评估疼痛严重程度,纳入疼痛评分大于3分的患者。
处置流程与药物剂量
- A组:静脉给予吗啡联合氟哌啶醇;B组:静脉给予吗啡联合生理盐水。
- 注射后0、20、40、60分钟记录疼痛严重程度。
研究设计与关键结果
- 随机双盲临床试验,共纳入140例急性肾绞痛患者,随机分为2组:A组接受静脉吗啡联合氟哌啶醇,B组接受静脉吗啡联合生理盐水。
- 两组疼痛严重程度评分比较无显著差异(P=0.38)。
- 两组平均心率、平均收缩压、平均舒张压及恶心呕吐平均发生率均无显著差异。
- 氟哌啶醇组锥体外系副作用发生率为4.3%,与另一组无显著差异。
- 两组额外镇痛需求频率无显著差异(P=0.05)。
证据类型、等级与局限
- 证据类型:随机双盲临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,在急性肾绞痛患者中,氟哌啶醇未能减轻疼痛及恶心呕吐发生率,反而引起锥体外系副作用,因此不推荐将该药物用于急性疼痛尤其肾绞痛。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Given the increasing number of patients with acute renal colic, the present study examined the analgesic effects of haloperidol with or without morphine in order to find an effective method with fewer side effects for pain reduction in these patients.
METHOD: In the present randomized double-blind clinical trial study, patients with a pain severity score of above 3 were randomly divided into 2 equal groups: Group A received intravenous morphine and haloperidol, and Group B received intravenous morphine with normal saline. Pain severity was recorded at Times 0, 20, 40, and 60 min following the injections based on a visual pain analog scale (VPAS) from 0 to 10.
RESULTS: A total of 140 patients were included in this study. A comparison of the recorded pain severity scores did not show a significant difference between the 2 study groups (P = 0.38). The mean heart rate, the mean systolic and diastolic blood pressures, and the mean incidence rate of nausea and vomiting were not significantly different between Group A and Group B. The frequency of extrapyramidal side effects was 4.3% in the haloperidol group, which was not significantly different from that of the other group. The frequency of extra analgesic requirement was not significantly different between the 2 groups (P = 0.05).
CONCLUSION: In our patients with acute renal colic, haloperidol failed to reduce pain and the incidence of nausea or vomiting, while it caused extrapyramidal side effects. Therefore, the prescription of this medication for acute pains, especially in renal colic, is not recommended.
参考来源
- Masoumi K, Delirrooyfard A, Salehzadeh M, et al. Comparison of the analgesic effects of haloperidol with or without morphine in patients with acute renal colic: A randomized double-blind clinical trial study. Am J Emerg Med. 2018. PMID: 30366744. doi:10.1016/j.ajem.2018.10.031
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。